G-Zide MR Gliclazide 30mg Modified-Release Diabetes Tablets 28s

• Modified-release oral antidiabetic tablet for type 2 diabetes management • Contains gliclazide 30mg to stimulate insulin release • Pack of 28 tablets for once-daily dosing • Suitable for adults with type 2 diabetes mellitus • Dermatologically tested for tolerability in diabetic patients

G-Zide MR 30mg Tablets 28 Tablets is a modified-release formulation of gliclazide, an oral sulfonylurea medication used to treat type 2 diabetes mellitus in adults. It works by stimulating the beta cells in the pancreas to release more insulin in response to meals, helping to lower blood glucose levels and improve insulin sensitivity. This pack provides 28 tablets for convenient once-daily use alongside a balanced diet and exercise. It reduces the risk of long-term diabetes complications such as kidney damage, nerve issues, and blindness. The hydrophilic matrix ensures progressive release over 24 hours, maintaining steady glucose control without peak fluctuations. Not suitable for type 1 diabetes or diabetic ketoacidosis; consult a physician for personalized dosing. Benefits • Effectively lowers fasting and postprandial blood glucose levels • Improves insulin response to prevent hyperglycemia • Reduces risk of diabetes-related complications like kidney damage and blindness • Once-daily dosing enhances patient compliance and convenience • Antioxidant properties support vascular health independent of glucose control How to Use • Take one tablet daily with breakfast or the first main meal • Swallow whole with a glass of water; do not crush, chew, or break • Follow prescribed dose; doctor may adjust based on blood sugar monitoring • Combine with regular exercise and a diabetes-friendly diet • If a dose is missed, take as soon as remembered unless near next dose; do not double u